← Browse by Condition
Medical Condition
atherosclerosis cardiovascular disease
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2, Phase 3
NCT07104487 Phase 2
Recruiting
[18F]AlF-NOTA-octreotide PET/MRI in Carotid Artery Disease
Enrollment
24 pts
Location
Belgium
Sponsor
Universitaire Ziekenhuizen KU ...
NCT07241390 Phase 3
Recruiting
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
Enrollment
7,140 pts
Location
Argentina, Australia...
Sponsor
Eli Lilly and Company